Clinical trials are integral to Peter Mac’s unique standing as a research-oriented public cancer hospital and the foundation upon which clinical medicine is practised.
Clinical trials are research studies that test new medical treatments that are not yet available to the general public. They are used to gather more information about how effective a treatment is for humans and form an important part of Peter Mac’s role as a research-based cancer hospital.
There are more than 200 clinical trials active in cancer at Peter Mac at any one time. Trials commonly involve new cancer medicines but also examine new approaches to surgery, radiation therapy, supportive care, pain control and better ways of detecting the spread of tumours.
Peter Mac’s clinical trials teams use cutting-edge approaches, including sophisticated cancer imaging technologies, to evaluate the body's responses to new treatments. This is done safely and in close collaboration with our research laboratories and clinical areas.
Our research leaders are world-renowned. Many also treat people with cancer, so they are well placed to challenge conventional thinking in the pursuit of safer, gentler and more effective cancer treatment.